Related Experiment Video
Updated: Dec 13, 2025

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
Evaluating a personalized treatment for substance use disorder in people with mild intellectual disability or
Lotte C F Gosens1,2, Roy Otten1,2,3, Robert Didden2,4
1Research and Development, Pluryn, P.O. Box 53, 6500, AB, Nijmegen, the Netherlands.
Background:
The prevalence of substance use disorder (SUD) in people with Mild Intellectual Disabilities or Borderline Intellectual Functioning (MID-BIF) is high. However, an effective personalized treatment for people with MID-BIF and SUD is lacking. This paper describes the study protocol of the effectiveness study of Take it Personal!+, a personalized treatment for people with MID-BIF and SUD.
Methods:
The effectiveness of Take it Personal!+ in decreasing substance use will be assessed in a non-concurrent multiple baseline across individuals design comprising ten participants with MID-BIF and SUD. The participants with MID-BIF and SUD will be randomly allocated to one of the five baseline lengths (7-11 days). Substance use, will be assessed during baseline, intervention, and post-treatment phase using a daily diary method.
Discussion:
If this study shows that Take it Personal!+ is effective in decreasing substance use, the gap in treatment for people with MID-BIF and SUD will be filled.
Trial Registration:
The study is registered in the Netherlands Trial Register (Trial NL4935, registered July 2, 2019).
More Related Videos
Related Concept Videos
Intellectual Disability
Dosage Regimen: Individualization
Blind Procedures
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
Bioavailability Study Design: Single Versus Multiple Dose Studies
Dosage Regimens: Designs and Approaches

